To determine whether allogeneic bone-marrow transplantation is associated with a graft-versus-leukemia effect, we examined the relation between relapse of leukemia and graft-versus-host disease in 46 recipients of identical-twin (syngeneic) marrow, 117 recipients of HLA-identical-sibling (allogeneic) marrow with no or minimal graft-versus-host disease, and 79 recipients of allogeneic marrow with moderate to severe or chronic disease. The relative relapse rate was 2.5 times less in allogeneic-marrow recipients with graft-versus-host disease than in recipients without it (P less than 0.01). This apparent antileukemic effect was more marked in patients with lymphoblastic than nonlymphoblastic leukemia, and in those who received transplants during relapse rather than during remission, and was most evident during the first 130 days after transplantation. Survival of all patients was comparable since the lesser probability of recurrent leukemia in patients with graft-versus-host disease was offset by a greater probability of other causes of death.
This article has been cited by other articles:
Rowe, J. M.
(2008). Allografting in ALL: the net widens. Blood
112: 212-212
[Full Text]
Fouillard, L., Labopin, M., Gratwohl, A., Gluckman, E., Frassoni, F., Beelen, D. W., Willemze, R., Montserrat, E., Blaise, D., Atienza, A. I., Sierra, J., Santos, M., Gorin, N.-C., Rocha, V., on behalf of the Acute Leukemia Working Party of t,
(2008). Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission. haematol
93: 834-841
[Abstract][Full Text]
Eto, M., Kamiryo, Y., Takeuchi, A., Harano, M., Tatsugami, K., Harada, M., Kiyoshima, K., Hamaguchi, M., Teshima, T., Tsuneyoshi, M., Yoshikai, Y., Naito, S.
(2008). Posttransplant Administration of Cyclophosphamide and Donor Lymphocyte Infusion Induces Potent Antitumor Immunity to Solid Tumor. Clin. Cancer Res.
14: 2833-2840
[Abstract][Full Text]
Goldstone, A. H., Richards, S. M., Lazarus, H. M., Tallman, M. S., Buck, G., Fielding, A. K., Burnett, A. K., Chopra, R., Wiernik, P. H., Foroni, L., Paietta, E., Litzow, M. R., Marks, D. I., Durrant, J., McMillan, A., Franklin, I. M., Luger, S., Ciobanu, N., Rowe, J. M.
(2008). In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood
111: 1827-1833
[Abstract][Full Text]
Mackinnon, S.
(2008). Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation. Am Soc Clin Oncol Ed Book
2008: 334-337
[Abstract][Full Text]
Yoshida, Y., Hirano, T., Son, G., Iimuro, Y., Imado, T., Iwasaki, T., Fujimoto, J.
(2007). Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease. Am. J. Physiol. Gastrointest. Liver Physiol.
293: G1114-G1123
[Abstract][Full Text]
Schmitz, N., Dreger, P., Glass, B., Sureda, A.
(2007). Allogeneic transplantation in lymphoma: current status. haematol
92: 1533-1548
[Abstract][Full Text]
Choi, S. W., Hildebrandt, G. C., Olkiewicz, K. M., Hanauer, D. A., Chaudhary, M. N., Silva, I. A., Rogers, C. E., Deurloo, D. T., Fisher, J. M., Liu, C., Adams, D., Chensue, S. W., Cooke, K. R.
(2007). CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation. Blood
110: 3447-3455
[Abstract][Full Text]
Gadi, V. K., Nelson, J. L.
(2007). Fetal Microchimerism in Women with Breast Cancer. Cancer Res.
67: 9035-9038
[Abstract][Full Text]
Rowe, J. M., Goldstone, A. H.
(2007). How I treat acute lymphocytic leukemia in adults. Blood
110: 2268-2275
[Abstract][Full Text]
Tallman, M. S., Dewald, G. W., Gandham, S., Logan, B. R., Keating, A., Lazarus, H. M., Litzow, M. R., Mehta, J., Pedersen, T., Perez, W. S., Rowe, J. M., Wetzler, M., Weisdorf, D. J.
(2007). Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. Blood
110: 409-417
[Abstract][Full Text]
Perez-Garcia, A., De la Camara, R., Roman-Gomez, J., Jimenez-Velasco, A., Encuentra, M., Nieto, J. B., de la Rubia, J., Urbano-Ispizua, A., Brunet, S., Iriondo, A., Gonzalez, M., Serrano, D., Espigado, I., Solano, C., Ribera, J. M., Pujal, J. M., Hoyos, M., Gallardo, D., the GVHD/Immunotherapy Committee of the Spanish Gr,
(2007). CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.. Blood
110: 461-467
[Abstract][Full Text]
Sinai, P., Berg, R. E., Haynie, J. M., Egorin, M. J., Ilaria, R. L. Jr, Forman, J.
(2007). Imatinib Mesylate Inhibits Antigen-Specific Memory CD8 T Cell Responses In Vivo. J. Immunol.
178: 2028-2037
[Abstract][Full Text]
Eto, M., Harano, M., Tatsugami, K., Harada, M., Kamiryo, Y., Kiyoshima, K., Hamaguchi, M., Tsuneyoshi, M., Yoshikai, Y., Naito, S.
(2007). Cyclophosphamide-Using Nonmyeloablative Allogeneic Cell Therapy against Renal Cancer with a Reduced Risk of Graft-versus-Host Disease. Clin. Cancer Res.
13: 1029-1035
[Abstract][Full Text]
Ueha, S., Murai, M., Yoneyama, H., Kitabatake, M., Imai, T., Shimaoka, T., Yonehara, S., Ishikawa, S., Matsushima, K.
(2007). Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects. J. Leukoc. Biol.
81: 176-185
[Abstract][Full Text]
Antin, J. H.
(2007). Reduced-Intensity Stem Cell Transplantation: "...whereof a little More than a little is by much too much." King Henry IV, part 1, I, 2. ASH Education Book
2007: 47-54
[Abstract][Full Text]
Yang, J. C., Childs, R.
(2006). Immunotherapy for Renal Cell Cancer. JCO
24: 5576-5583
[Abstract][Full Text]
Chakraverty, R., Eom, H.-S., Sachs, J., Buchli, J., Cotter, P., Hsu, R., Zhao, G., Sykes, M.
(2006). Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions. Blood
108: 2106-2113
[Abstract][Full Text]
Baron, F., Storb, R., Storer, B. E., Maris, M. B., Niederwieser, D., Shizuru, J. A., Chauncey, T. R., Bruno, B., Forman, S. J., McSweeney, P. A., Maziarz, R. T., Pulsipher, M. A., Agura, E. D., Wade, J., Sorror, M., Maloney, D. G., Sandmaier, B. M.
(2006). Factors Associated With Outcomes in Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning After Failed Myeloablative Hematopoietic Cell Transplantation. JCO
24: 4150-4157
[Abstract][Full Text]
Barkholt, L., Bregni, M., Remberger, M., Blaise, D., Peccatori, J., Massenkeil, G., Pedrazzoli, P., Zambelli, A., Bay, J.-O., Francois, S., Martino, R., Bengala, C., Brune, M., Lenhoff, S., Porcellini, A., Falda, M., Siena, S., Demirer, T., Niederwieser, D., Ringden, O., On behalf of the French ITAC group and the EBMT So,
(2006). Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe. Ann Oncol
17: 1134-1140
[Abstract][Full Text]
Pirson, L., Baron, F., Meuris, N., Giet, O., Castermans, E., Greimers, R., Di Stefano, I., Gothot, A., Beguin, Y.
(2006). Despite Inhibition of Hematopoietic Progenitor Cell Growth In Vitro, the Tyrosine Kinase Inhibitor Imatinib Does Not Impair Engraftment of Human CD133+ Cells into NOD/SCID{beta}2mNull Mice. Stem Cells
24: 1814-1821
[Abstract][Full Text]
Copelan, E. A.
(2006). Hematopoietic stem-cell transplantation.. NEJM
354: 1813-1826
[Full Text]
Harano, M., Eto, M., Iwai, T., Tatsugami, K., Kiyoshima, K., Kamiryo, Y., Tsuneyoshi, M., Yoshikai, Y., Naito, S.
(2005). Renal Cancer Treatment with Low Levels of Mixed Chimerism Induced by Nonmyeloablative Regimen Using Cyclophosphamide in Mice. Cancer Res.
65: 10032-10040
[Abstract][Full Text]
Roman, E., Cooney, E., Harrison, L., Militano, O., Wolownik, K., Hawks, R., Foley, S., Satwani, P., Unal, E., Bhatia, M., Bradley, B., Del Toro, G., George, D., Garvin, J., van de Ven, C., Cairo, M. S.
(2005). Preliminary Results of the Safety of Immunotherapy with Gemtuzumab Ozogamicin following Reduced Intensity Allogeneic Stem Cell Transplant in Children with CD33+ Acute Myeloid Leukemia. Clin. Cancer Res.
11: 7164s-7170s
[Abstract][Full Text]
Donnenberg, V. S., Donnenberg, A. D.
(2005). Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis. J Clin Pharmacol
45: 872-877
[Abstract][Full Text]
Lee, S., Kim, Y.-J., Min, C.-K., Kim, H.-J., Eom, K.-S., Kim, D.-W., Lee, J.-W., Min, W.-S., Kim, C.-C.
(2005). The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood
105: 3449-3457
[Abstract][Full Text]
Schrier, R. W., Parikh, C. R.
(2005). Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation. Nephrol Dial Transplant
20: 678-683
[Full Text]
Baron, F., Maris, M. B., Sandmaier, B. M., Storer, B. E., Sorror, M., Diaconescu, R., Woolfrey, A. E., Chauncey, T. R., Flowers, M. E.D., Mielcarek, M., Maloney, D. G., Storb, R.
(2005). Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning. JCO
23: 1993-2003
[Abstract][Full Text]
Suzuki, Y., Adachi, Y., Minamino, K., Zhang, Y., Iwasaki, M., Nakano, K., Koike, Y., Ikehara, S.
(2005). A New Strategy for Treatment of Malignant Tumor: Intra-Bone Marrow-Bone Marrow Transplantation Plus CD4- Donor Lymphocyte Infusion. Stem Cells
23: 365-370
[Abstract][Full Text]
Krause, D. S., Van Etten, R. A.
(2004). Adoptive immunotherapy of BCR-ABL-induced chronic myeloid leukemia-like myeloproliferative disease in a murine model. Blood
104: 4236-4244
[Abstract][Full Text]
Kami, M., Makimoto, A., Heike, Y., Takaue, Y.
(2004). Reduced-intensity Hematopoietic Stem Cell Transplantation (RIST) for Solid Malignancies. Jpn J Clin Oncol
34: 707-716
[Abstract][Full Text]
Dominietto, A., Raiola, A. M., Grasso, R., Garuti, A., di Grazia, C., Bregante, S., Gualandi, F., Ibatici, A., Lamparelli, T., van Lint, M. T., Frassoni, F., Bacigalupo, A.
(2004). Molecular Relapse of Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Can Be Successfully Treated with Donor Lymphocyte Infusions.. ASH ANNUAL MEETING ABSTRACTS
104: 5122-5122
[Abstract]
Miura, Y., Thoburn, C. J., Bright, E. C., Phelps, M. L., Shin, T., Matsui, E. C., Matsui, W. H., Arai, S., Fuchs, E. J., Vogelsang, G. B., Jones, R. J., Hess, A. D.
(2004). Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood
104: 2187-2193
[Abstract][Full Text]
Takahashi, Y., Childs, R. W.
(2004). Nonmyeloablative Transplantation: An Allogeneic-Based Immunotherapy for Renal Cell Carcinoma. Clin. Cancer Res.
10: 6353S-6359S
[Abstract][Full Text]
Stelljes, M., Strothotte, R., Pauels, H.-G., Poremba, C., Milse, M., Specht, C., Albring, J., Bisping, G., Scheffold, C., Kammertoens, T., Oelmann, E., Silling, G., Berdel, W. E., Kienast, J.
(2004). Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets. Blood
104: 1210-1216
[Abstract][Full Text]
Bader, P., Kreyenberg, H., Hoelle, W., Dueckers, G., Handgretinger, R., Lang, P., Kremens, B., Dilloo, D., Sykora, K.-W., Schrappe, M., Niemeyer, C., von Stackelberg, A., Gruhn, B., Henze, G., Greil, J., Niethammer, D., Dietz, K., Beck, J. F., Klingebiel, T.
(2004). Increasing Mixed Chimerism Is an Important Prognostic Factor for Unfavorable Outcome in Children With Acute Lymphoblastic Leukemia After Allogeneic Stem-Cell Transplantation: Possible Role For Pre-Emptive Immunotherapy?. JCO
22: 1696-1705
[Abstract][Full Text]
Mapara, M. Y., Sykes, M.
(2004). Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance. JCO
22: 1136-1151
[Abstract][Full Text]
Nusair, S., Breuer, R., Shapira, M.Y., Berkman, N., Or, R.
(2004). Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation. Eur Respir J
23: 440-445
[Abstract][Full Text]
Randolph, S. S. B., Gooley, T. A., Warren, E. H., Appelbaum, F. R., Riddell, S. R.
(2004). Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood
103: 347-352
[Abstract][Full Text]
Ueno, N. T., Cheng, Y. C., Rondon, G., Tannir, N. M., Gajewski, J. L., Couriel, D. R., Hosing, C., de Lima, M. J., Anderlini, P., Khouri, I. F., Booser, D. J., Hortobagyi, G. N., Pagliaro, L. C., Jonasch, E., Giralt, S. A., Champlin, R. E.
(2003). Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors. Blood
102: 3829-3836
[Abstract][Full Text]
Bishop, M. R.
(2003). The Graft-Versus-Lymphoma Effect: Fact, Fiction, or Opportunity?. JCO
21: 3713-3715
[Full Text]
Antin, J. H.
(2003). A 41-Year-Old Woman With Chronic Myelogenous Leukemia. JAMA
290: 1083-1090
[Full Text]
Mohty, M., Bay, J.-O., Faucher, C., Choufi, B., Bilger, K., Tournilhac, O., Vey, N., Stoppa, A.-M., Coso, D., Chabannon, C., Viens, P., Maraninchi, D., Blaise, D.
(2003). Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen. Blood
102: 470-476
[Abstract][Full Text]
Grewal, S. S., Barker, J. N., Davies, S. M., Wagner, J. E.
(2003). Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?. Blood
101: 4233-4244
[Full Text]
Worth, A., Rao, K., Webb, D., Chessells, J., Passmore, J., Veys, P.
(2003). Successful treatment of juvenile myelomonocytic leukemia relapsing after stem cell transplantation using donor lymphocyte infusion. Blood
101: 1713-1714
[Abstract][Full Text]
Michalek, J., Collins, R. H., Durrani, H. P., Vaclavkova, P., Ruff, L. E., Douek, D. C., Vitetta, E. S.
(2003). Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences. Proc. Natl. Acad. Sci. USA
100: 1180-1184
[Abstract][Full Text]
Storb, R. F., Lucarelli, G., McSweeney, P. A., Childs, R. W.
(2003). Hematopoietic Cell Transplantation for Benign Hematological Disorders and Solid Tumors. ASH Education Book
2003: 372-397
[Abstract][Full Text]
Ringden, O., Labopin, M., Bacigalupo, A., Arcese, W., Schaefer, U.W., Willemze, R., Koc, H., Bunjes, D., Gluckman, E., Rocha, V., Schattenberg, A., Frassoni, F.
(2002). Transplantation of Peripheral Blood Stem Cells as Compared With Bone Marrow From HLA-Identical Siblings in Adult Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia. JCO
20: 4655-4664
[Abstract][Full Text]
Robinson, S. P., Goldstone, A. H., Mackinnon, S., Carella, A., Russell, N., de Elvira, C. R., Taghipour, G., Schmitz, N.
(2002). Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. Blood
100: 4310-4316
[Abstract][Full Text]
Gratwohl, A., Brand, R., Apperley, J., Biezen, A. v., Bandini, G., Devergie, A., Schattenberg, A., Frassoni, F., Guglielmi, C., Iacobelli, S., Michallet, M., Kolb, H.-J., Ruutu, T., Niederwieser, D.
(2002). Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood
100: 3877-3886
[Abstract][Full Text]
Miura, Y., Thoburn, C. J., Bright, E. C., Chen, W., Nakao, S., Hess, A. D.
(2002). Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD. Blood
100: 2650-2658
[Abstract][Full Text]
Mapara, M. Y., Kim, Y.-M., Wang, S.-P., Bronson, R., Sachs, D. H., Sykes, M.
(2002). Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood
100: 1903-1909
[Abstract][Full Text]
Tabbara, I. A., Zimmerman, K., Morgan, C., Nahleh, Z.
(2002). Allogeneic Hematopoietic Stem Cell Transplantation: Complications and Results. Arch Intern Med
162: 1558-1566
[Abstract][Full Text]
Guardiola, P., Runde, V., Bacigalupo, A., Ruutu, T., Locatelli, F., Boogaerts, M. A., Pagliuca, A., Cornelissen, J. J., Schouten, H. C., Carreras, E., Finke, J., van Biezen, A., Brand, R., Niederwieser, D., Gluckman, E., de Witte, T. M.
(2002). Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. Blood
99: 4370-4378
[Abstract][Full Text]
Morishima, Y., Sasazuki, T., Inoko, H., Juji, T., Akaza, T., Yamamoto, K., Ishikawa, Y., Kato, S., Sao, H., Sakamaki, H., Kawa, K., Hamajima, N., Asano, S., Kodera, Y.
(2002). The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood
99: 4200-4206
[Abstract][Full Text]
Appelbaum, F. R., Sandmaier, B.
(2002). Sensitivity of Renal Cell Cancer to Nonmyeloablative Allogeneic Hematopoietic Cell Transplantations: Unusual or Unusually Important?. JCO
20: 1965-1967
[Full Text]
Maloney, D. G., Sandmaier, B. M., Mackinnon, S., Shizuru, J. A.
(2002). Non-Myeloablative Transplantation. ASH Education Book
2002: 392-421
[Abstract][Full Text]
Ho, V. T., Soiffer, R. J.
(2001). The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood
98: 3192-3204
[Full Text]
Montagna, D., Maccario, R., Locatelli, F., Rosti, V., Yang, Y., Farness, P., Moretta, A., Comoli, P., Montini, E., Vitiello, A.
(2001). Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy. Blood
98: 3359-3366
[Abstract][Full Text]
Uzunel, M., Mattsson, J., Jaksch, M., Remberger, M., Ringden, O.
(2001). The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia. Blood
98: 1982-1985
[Abstract][Full Text]
Michallet, M., Bilger, K., Garban, F., Attal, M., Huyn, A., Blaise, D., Milpied, N., Moreau, P., Bordigoni, P., Kuentz, M., Sadoun, A., Cahn, J.-Y., Socie, G., Thomas, X., Arnaud, P., Raus, N., Lheritier, V., Pigneux, A., Boiron, J.-M.
(2001). Allogeneic Hematopoietic Stem-Cell Transplantation After Nonmyeloablative Preparative Regimens: Impact of Pretransplantation and Posttransplantation Factors on Outcome. JCO
19: 3340-3349
[Abstract][Full Text]
FEINSTEIN, L., SANDMAIER, B., MALONEY, D., McSWEENEY, P. A., MARIS, M., FLOWERS, C., RADICH, J., LITTLE, M.-T., NASH, R. A., CHAUNCEY, T., WOOLFREY, A., GEORGES, G., KIEM, H.-P., ZAUCHA, J. M., BLUME, K. G., SHIZURU, J., NIEDERWIESER, D., STORB, R.
(2001). Nonmyeloablative Hematopoietic Cell Transplantation: Replacing High-Dose Cytotoxic Therapy by the Graft-versus-Tumor Effect. Ann. N. Y. Acad. Sci.
938: 328-339
[Abstract][Full Text]
McSweeney, P. A., Niederwieser, D., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., Radich, J., Wagner, J. L., Minor, S., Appelbaum, F. R., Bensinger, W. I., Bryant, E., Flowers, M. E. D., Georges, G. E., Grumet, F. C., Kiem, H.-P., Torok-Storb, B., Yu, C., Blume, K. G., Storb, R. F.
(2001). Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood
97: 3390-3400
[Abstract][Full Text]
Notter, M., Willinger, T., Erben, U., Thiel, E.
(2001). Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells. Blood
97: 3138-3145
[Abstract][Full Text]
Storb, R. F., Champlin, R., Riddell, S. R., Murata, M., Bryant, S., Warren, E. H.
(2001). Non-Myeloablative Transplants for Malignant Disease. ASH Education Book
2001: 375-391
[Abstract][Full Text]
Kottaridis, P. D., Milligan, D. W., Chopra, R., Chakraverty, R. K., Chakrabarti, S., Robinson, S., Peggs, K., Verfuerth, S., Pettengell, R., Marsh, J. C. W., Schey, S., Mahendra, P., Morgan, G. J., Hale, G., Waldmann, H., de Elvira, M. C. R., Williams, C. D., Devereux, S., Linch, D. C., Goldstone, A. H., Mackinnon, S.
(2000). In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood
96: 2419-2425
[Abstract][Full Text]
Childs, R., Chernoff, A., Contentin, N., Bahceci, E., Schrump, D., Leitman, S., Read, E. J., Tisdale, J., Dunbar, C., Linehan, W. M., Young, N. S., Barrett, A. J.
(2000). Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation. NEJM
343: 750-758
[Abstract][Full Text]
Hsieh, M. H., Korngold, R.
(2000). Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses. Blood
96: 1047-1055
[Abstract][Full Text]
Barrett, A. J., Ringden, O., Zhang, M.-J., Bashey, A., Cahn, J.-Y., Cairo, M. S., Gale, R. P., Gratwohl, A., Locatelli, F., Martino, R., Schultz, K. R., Tiberghien, P., the GVHD/GVL Working Committee of the Internationa,
(2000). Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. Blood
95: 3323-3327
[Abstract][Full Text]
Chambost, H., Van Baren, N., Brasseur, F., Godelaine, D., Xerri, L., Landi, S. J., Theate, I., Plumas, J., Spagnoli, G. C., Michel, G., Coulie, P. G., Olive, D.
(2000). Expression of gene MAGE-A4 in Reed-Sternberg cells. Blood
95: 3530-3533
[Abstract][Full Text]
Borrello, I., Sotomayor, E. M., Rattis, F.-M., Cooke, S. K., Gu, L., Levitsky, H. I.
(2000). Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines. Blood
95: 3011-3019
[Abstract][Full Text]
Engels, F. H. C., Koski, G. K., Bedrosian, I., Xu, S., Luger, S., Nowell, P. C., Cohen, P. A., Czerniecki, B. J.
(1999). Calcium signaling induces acquisition of dendritic cell characteristics in chronic myelogenous leukemia myeloid progenitor cells. Proc. Natl. Acad. Sci. USA
96: 10332-10337
[Abstract][Full Text]
Bonnet, D., Warren, E. H., Greenberg, P. D., Dick, J. E., Riddell, S. R.
(1999). CD8+ minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proc. Natl. Acad. Sci. USA
96: 8639-8644
[Abstract][Full Text]
Ringden, O., Remberger, M., Runde, V., Bornhauser, M., Blau, I.W., Basara, N., Holig, K., Beelen, D.W., Hagglund, H., Basu, O., Ehninger, G., Fauser, A.A.
(1999). Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow Transplantation. Blood
94: 455-464
[Abstract][Full Text]
Childs, R. W., Clave, E., Tisdale, J., Plante, M., Hensel, N., Barrett, J.
(1999). Successful Treatment of Metastatic Renal Cell Carcinoma With a Nonmyeloablative Allogeneic Peripheral-Blood Progenitor-Cell Transplant: Evidence for a Graft-Versus-Tumor Effect. JCO
17: 2044-2044
[Abstract][Full Text]
Yoshida, R., Yoneda, Y., Kuriyama, M., Kubota, T.
(1999). IFN-{gamma}- and Cell-to-Cell Contact-Dependent Cytotoxicity of Allograft-Induced Macrophages Against Syngeneic Tumor Cells and Cell Lines: An Application of Allografting to Cancer Treatment. J. Immunol.
163: 148-154
[Abstract][Full Text]
Locatelli, F., Rocha, V., Chastang, C., Arcese, W., Michel, G., Abecasis, M., Messina, C., Ortega, J., Badell-Serra, I., Plouvier, E., Souillet, G., Jouet, J.-P., Pasquini, R., Ferreira, E., Garnier, F., Gluckman, E.
(1999). Factors Associated With Outcome After Cord Blood Transplantation in Children With Acute Leukemia. Blood
93: 3662-3671
[Abstract][Full Text]
Montagna, D., Yvon, E., Calcaterra, V., Comoli, P., Locatelli, F., Maccario, R., Fisher, A., Cavazzana-Calvo, M.
(1999). Depletion of Alloreactive T Cells by a Specific Anti-Interleukin-2 Receptor p55 Chain Immunotoxin Does Not Impair In Vitro Antileukemia and Antiviral Activity. Blood
93: 3550-3557
[Abstract][Full Text]
Tsukada, N., Kobata, T., Aizawa, Y., Yagita, H., Okumura, K.
(1999). Graft-Versus-Leukemia Effect and Graft-Versus-Host Disease Can Be Differentiated by Cytotoxic Mechanisms in a Murine Model of Allogeneic Bone Marrow Transplantation. Blood
93: 2738-2747
[Abstract][Full Text]
Sasazuki, T., Juji, T., Morishima, Y., Kinukawa, N., Kashiwabara, H., Inoko, H., Yoshida, T., Kimura, A., Akaza, T., Kamikawaji, N., Kodera, Y., Takaku, F., Nose, Y., Ono, T., Sakamaki, T., Kato, S., Akiyama, Y., Okamoto, S., Dohy, H., Harada, M., Asano, S., The Japan Marrow Donor Program,
(1998). Effect of Matching of Class I HLA Alleles on Clinical Outcome after Transplantation of Hematopoietic Stem Cells from an Unrelated Donor. NEJM
339: 1177-1185
[Abstract][Full Text]
Maruya, E., Saji, H., Seki, S., Fujii, Y., Kato, K., Kai, S., Hiraoka, A., Kawa, K., Hoshi, Y., Ito, K., Yokoyama, S., Juji, T.
(1998). Evidence That CD31, CD49b, and CD62L Are Immunodominant Minor Histocompatibility Antigens in HLA Identical Sibling Bone Marrow Transplants. Blood
92: 2169-2176
[Abstract][Full Text]
Mutis, T., Schrama, E., Melief, C. J.M., Goulmy, E.
(1998). CD80-Transfected Acute Myeloid Leukemia Cells Induce Primary Allogeneic T-Cell Responses Directed at Patient Specific Minor Histocompatibility Antigens and Leukemia-Associated Antigens. Blood
92: 1677-1684
[Abstract][Full Text]
Smit, W. M., Rijnbeek, M., van Bergen, C. A. M., Fibbe, W. E., Willemze, R., Falkenburg, J. H. F.
(1998). T cells recognizing leukemic CD34+ progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proc. Natl. Acad. Sci. USA
95: 10152-10157
[Abstract][Full Text]
Lokhorst, H.M., Schattenberg, A., Cornelissen, J.J., Thomas, L.L.M., Verdonck, L.F.
(1997). Donor Leukocyte Infusions Are Effective in Relapsed Multiple Myeloma After Allogeneic Bone Marrow Transplantation. Blood
90: 4206-4211
[Abstract][Full Text]
Ferrant, A., Labopin, M., Frassoni, F., Prentice, H.G., Cahn, J.Y., Blaise, D., Reiffers, J., Visani, G., Sanz, M.A., Boogaerts, M.A., Lowenberg, B., Gorin, N.C.
(1997). Karyotype in Acute Myeloblastic Leukemia: Prognostic Significance for Bone Marrow Transplantation in First Remission: A European Group for Blood and Marrow Transplantation Study. Blood
90: 2931-2938
[Abstract][Full Text]
Glass, B., Uharek, L., Zeis, M., Dreger, P., Loffler, H., Steinmann, J., Schmitz, N.
(1997). Allogeneic Peripheral Blood Progenitor Cell Transplantation in a Murine Model: Evidence for an Improved Graft-Versus-Leukemia Effect. Blood
90: 1694-1700
[Abstract][Full Text]
Mutis, T., Schrama, E., A.P. van Luxemburg-Heijs, S., Falkenburg, J.H.F, Melief, C. J.M., Goulmy, E.
(1997). HLA Class II Restricted T-Cell Reactivity to a Developmentally Regulated Antigen Shared by Leukemic Cells and CD34+ Early Progenitor Cells. Blood
90: 1083-1090
[Abstract][Full Text]
Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondon, G., Anderlini, P., O'Brien, S., Khouri, I., Gajewski, J., Mehra, R., Claxton, D., Andersson, B., Beran, M., Przepiorka, D., Koller, C., Kornblau, S., Korbling, M., Keating, M., Kantarjian, H., Champlin, R.
(1997). Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy. Blood
89: 4531-4536
[Abstract][Full Text]
Soiffer, R. J., Fairclough, D., Robertson, M., Alyea, E., Anderson, K., Freedman, A., Bartlett-Pandite, L., Fisher, D., Schlossman, R. L., Stone, R., Murray, C., Freeman, A., Marcus, K., Mauch, P., Nadler, L., Ritz, J.
(1997). CD6-Depleted Allogeneic Bone Marrow Transplantation for Acute Leukemia in First Complete Remission. Blood
89: 3039-3047
[Abstract][Full Text]
Rocha, M., Umansky, V., Lee, K.-H., Hacker, H.-J., Benner, A., Schirrmacher, V.
(1997). Differences Between Graft-Versus-Leukemia and Graft-Versus-Host Reactivity. I. Interaction of Donor Immune T Cells With Tumor and/or Host Cells. Blood
89: 2189-2202
[Abstract][Full Text]
Munshi, N.C., Govindarajan, R., Drake, R., Ding, L.M., Iyer, R., Saylors, R., Kornbluth, J., Marcus, S., Chiang, Y., Ennist, D., Kwak, L., Reynolds, C., Tricot, G., Barlogie, B.
(1997). Thymidine Kinase (TK) Gene-Transduced Human Lymphocytes Can Be Highly Purified, Remain Fully Functional, and Are Killed Efficiently With Ganciclovir. Blood
89: 1334-1340
[Abstract][Full Text]
Imrie, K, Dicke, K., Keating, A
(1996). Autologous bone marrow transplantation for acute myeloid leukemia. Stem Cells
14: 69-78
[Abstract]
Armitage, J. O.
(1994). Bone Marrow Transplantation. NEJM
330: 827-838
[Full Text]
Previous
